[Capillary ENT hemangioma].
Capillary hemangioma is considered to be one of the most widespread (frequently occurring) vascular ENT tumours. These neoplasms are usually localized in the nasal cavity, sometimes in the larynx or pharynx, and rarely in the outer or middle ear. The principal method for the treatment of this pathology is surgical intervention. Tumour destruction by laser and radiowave radiation finding wide application for the removal of hemangiomas does not substantially lighten the work of a surgeon; moreover the use of these tools is fraught with a high risk of serious intra- and postoperative complications. In an attempt to avoid or reduce bleeding in the course of surgical intervention we used for the first time hemostatic TachoComb and a Fibro-Vein solution. The mode of using these preparations is described in much detail because it determines to a large degree the efficacy and safety of the treatment. The possibility to combine the surgical intervention with the application of TachoComb and a Fibro-Vein solution is considered; also, the advantages of radiowave-induced destruction of hemangiomas are emphasized.
T V
TV
Antoniv
D000293:Adolescent; D000328:Adult; D007611:Aprotinin / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004338:Drug Combinations; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use*; D005500:Follow-Up Studies; D018324:Hemangioma, Capillary / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D010039:Otorhinolaryngologic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D012597:Sclerosing Solutions / Q000008:administration & dosage*; D012981:Sodium Tetradecyl Sulfate / Q000008:administration & dosage*; D013917:Thrombin / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
D004338:Drug Combinations; D012597:Sclerosing Solutions; C093991:tachocomb; D005340:Fibrinogen; D007611:Aprotinin; D013917:Thrombin; D012981:Sodium Tetradecyl Sulfate